FDA clears Biorez BioBrace implant technology

Biorez announced that it received FDA 510(k) clearance for two sizes of its BioBrace implant for tendon and ligament procedures.

New Haven, Conn.-based Biorez designed its biocomposite soft tissue scaffold for use in a range of surgical procedures to reinforce soft tissue where weakness exists, according to a news release. The implant can be used with existing surgical techniques and instrumentation.

The implant design includes a highly porous collagen matrix and resorbable PLLA microfilaments, offering a bio-inductive scaffold with strength to reinforce tendon and ligament repairs while promoting healing, Biorez said.

Additionally, the implant is fully resorbable and naturally broken down by the body as a change of pace from historical implant materials, which have been either synthetic or biologic, limiting their use and effectiveness as augmentation materials in tendon and ligament repair.

“We expect BioBrace to be a game…

Read more
  • 0

Biorez raises $3.5M for its BioBrace tech

Tendon and ligament repair technology developer Biorez announced today that it raised $3.5 million in a seed financing round.

New York Angels led the financing round, while Connecticut Innovations, Pritzker Vlock Family Office, Brainchild Holdings and The Vertical Group also participated, according to a news release.

The New Haven, Conn.-based company develops the BioBrace implant, which is comprised of a highly porous collagen sponge reinforced with bioresorbable microfilaments with the intention of augmenting and reinforcing a wide range of tendon and ligament procedures, including rotator cuff repair and ACL reconstruction.

Biorez said that the latest financing round adds to a previously raised $3.5 million, bringing its total funding at the moment to $7 million.

“Our vision is to help patients return to normal activity sooner and safer,” Biorez president & CEO Kevin Rocco said in the release. “BioBrace has the potent…

Read more
  • 0